FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to alkyl derivatives of trazodone of the general formula (I) where only one of R, R', R' and R''' means C1-3-alkyl and others are hydrogen, and their salts with physiologically acceptable an inorganic or an organic acids. Compounds are synthesized by interaction of compound of the formula (III) or its alkaline metal salt with piperazine compound of the formula (II) where R, R', R'' and R''' have values as indicated in the formula (I) and X means chlorine or bromine at boiling point or reaction mass. Compounds of the formula (I) show decreased affinity to adrenergic receptors as compared with trazodone but exceeds trazodone with respect to value LD50. EFFECT: improved method of synthesis, enhanced effectiveness of compounds. 10 cl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
(S) or (R) ENANTIOMERS, METHOD OF PREPARING THEREOF, AND INTERMEDIATE PRODUCT | 1994 |
|
RU2128180C1 |
SUBSTITUTED DERIVATIVES OF AZOLONE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF ITS PREPARING | 1994 |
|
RU2128659C1 |
PYRIDINONE PYRIDAZINONE DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE (PARP) | 2007 |
|
RU2472782C2 |
UREA DERIVATIVES AND THERAPEUTIC USE THEREOF IN TREATING, AMONG OTHER THINGS, RESPIRATORY TRACT DISEASES | 2011 |
|
RU2586223C2 |
TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO-[3,4-C]-1,2,4-TRIAZOLO- -[4,3-A]-PYRIDINES, METHOD OF INHIBITION OF ACTIVITY OF PHOSPHODIESTERASE TYPE IV AND METHOD OF INHIBITION OF TUMOR-SPECIFIC NECROSIS FACTOR PRODUCING | 1996 |
|
RU2161158C2 |
COMPOSITIONS AND METHODS OF TREATING COLITIS | 2010 |
|
RU2518416C2 |
TRIAZOLOPYRIDINE JAK INHIBITOR COMPOUNDS AND METHODS | 2009 |
|
RU2561104C2 |
KINASE INHIBITORS | 2012 |
|
RU2623734C9 |
ENZYMES INHIBITION | 2013 |
|
RU2638537C2 |
JAK-INHIBITING TRIAZOLOPYRIDINE COMPOUNDS AND METHODS | 2009 |
|
RU2560153C2 |
Authors
Dates
1999-02-27—Published
1993-01-14—Filed